JPS6316146B2 - - Google Patents

Info

Publication number

JPS6316146B2

JPS6316146B2 JP58014551A JP1455183A JPS6316146B2 JP S6316146 B2 JPS6316146 B2 JP S6316146B2 JP 58014551 A JP58014551 A JP 58014551A JP 1455183 A JP1455183 A JP 1455183A JP S6316146 B2 JPS6316146 B2 JP S6316146B2

Authority

JP

Japan

Prior art keywords

blood

plasma

membrane

air trap

discharge

Prior art date

1983-02-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Links

• Espacenet
• Global Dossier
• Discuss

• 210000004369 blood Anatomy 0.000 claims description 115
• 239000008280 blood Substances 0.000 claims description 115
• 239000012528 membrane Substances 0.000 claims description 54
• 238000000926 separation method Methods 0.000 claims description 15
• 239000000706 filtrate Substances 0.000 claims description 14
• 239000007788 liquid Substances 0.000 claims description 9
• 210000002381 plasma Anatomy 0.000 description 136
• 206010018910 Haemolysis Diseases 0.000 description 21
• 238000001914 filtration Methods 0.000 description 21
• 230000008588 hemolysis Effects 0.000 description 21
• 230000017531 blood circulation Effects 0.000 description 15
• 230000001105 regulatory effect Effects 0.000 description 10
• 210000003462 vein Anatomy 0.000 description 7
• 230000007423 decrease Effects 0.000 description 6
• 238000000034 method Methods 0.000 description 5
• 230000037452 priming Effects 0.000 description 4
• 210000001367 artery Anatomy 0.000 description 3
• 230000002093 peripheral effect Effects 0.000 description 3
• 230000002265 prevention Effects 0.000 description 3
• 108010085603 SFLLRNPND Proteins 0.000 description 2
• 210000000601 blood cell Anatomy 0.000 description 2
• 230000036772 blood pressure Effects 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 230000000694 effects Effects 0.000 description 2
• 239000005038 ethylene vinyl acetate Substances 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 238000012544 monitoring process Methods 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
• 239000003566 sealing material Substances 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 230000004872 arterial blood pressure Effects 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 229920005549 butyl rubber Polymers 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• 238000007599 discharging Methods 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 238000002637 fluid replacement therapy Methods 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 238000005534 hematocrit Methods 0.000 description 1
• 239000012510 hollow fiber Substances 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 229920003049 isoprene rubber Polymers 0.000 description 1
• 229920001684 low density polyethylene Polymers 0.000 description 1
• 239000004702 low-density polyethylene Substances 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• -1 organic acid esters Chemical class 0.000 description 1
• 238000005191 phase separation Methods 0.000 description 1
• 239000002504 physiological saline solution Substances 0.000 description 1
• 239000004417 polycarbonate Substances 0.000 description 1
• 229920000515 polycarbonate Polymers 0.000 description 1
• 229920001296 polysiloxane Polymers 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 238000003825 pressing Methods 0.000 description 1
• 102000004169 proteins and genes Human genes 0.000 description 1
• 108090000623 proteins and genes Proteins 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 238000007789 sealing Methods 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 239000000243 solution Substances 0.000 description 1
• 229920003048 styrene butadiene rubber Polymers 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 229920003002 synthetic resin Polymers 0.000 description 1
• 239000000057 synthetic resin Substances 0.000 description 1